Holen Sie sich die Stockscreener-App
0.4177
1.67%
-0.0071
Vorhandelsmarkt:
.42
0.0023
+0.55%
Schlusskurs vom Vortag:
$0.4248
Offen:
$0.4235
24-Stunden-Volumen:
1.84M
Relative Volume:
0.23
Marktkapitalisierung:
$61.22M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-0.6426
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+34.48%
1M Leistung:
+51.78%
6M Leistung:
-59.45%
1J Leistung:
-74.37%
1-Tages-Spanne:
$0.3808
$0.4248
1-Wochen-Bereich:
$0.303
$0.428
52-Wochen-Spanne:
$0.1718
$2.04
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.4177 | 52.76M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
475.03 | 176.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.81 | 141.70B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
549.97 | 43.48B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
200.82 | 33.02B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.35 | 33.01B | 6.63B | 1.17B | 1.19B | 4.05 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Is Biodesix Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com
Biodesix Inc. Stock Analysis and ForecastFree Stock Selection - PrintWeekIndia
AIGH Capital Management LLC Reduces Stock Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Is Biodesix Inc. a good long term investmentExplosive returns - PrintWeekIndia
How Biodesix Inc. stock compares to its top competitorsIs CHARU stock undervalued or overvalued nowFastest-growing stock picks - jammulinksnews.com
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Biodesix, Inc. to Announce Second Quarter 2025 Financial Results on August 7 - Quiver Quantitative
Biodesix Announces Q2 2025 Earnings Call: Key Financial Results Coming August 7 - Stock Titan
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire Inc.
12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey
What drives Biodesix Inc. stock priceFree High-Return Strategy Alerts - jammulinksnews.com
What analysts say about Biodesix Inc. stockSpectacular growth rates - jammulinksnews.com
How Biodesix Inc. stock performs during market volatilityFree Popular Stock Recommendations - Newser
What makes Biodesix Inc. stock price move sharplySmart Trading With Safety Margin - Newser
Why Biodesix Inc. stock attracts strong analyst attentionFree Access to Investors Club - Newser
Biodesix (NASDAQ:BDSX) Trading 0.4% Higher – Time to Buy? - Defense World
Investors Give Biodesix, Inc. (NASDAQ:BDSX) Shares A 27% Hiding - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 127.0% in May - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Stock Rockets 30% But Many Are Still Ignoring The Company - simplywall.st
Millennium Management LLC Buys 33,329 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix (BDSX) Partners with APAPP to Enhance Lung Cancer Care - GuruFocus
Biodesix, Inc. Partners with Association of Pulmonary Advanced Practice Providers to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - MarketScreener
Biodesix Partners with Association of Pulmonary Advanced Practic - GuruFocus
Biodesix partners with Association of Pulmonary APPs for lung cancer education - TipRanks
Public market insider buying at Freehold Royalties (FRU) - The Globe and Mail
Biodesix Partners with Association of Pulmonary Advanced - GlobeNewswire
Biodesix Partners with APAPP to Enhance Lung Cancer Education and Access to Diagnostic Tools - Nasdaq
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):